Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Hutchison Medipharma Limited
Scientific Title
A Phase I, open-label, dose-escalation study of the safety and pharmacokinetics of HMPL-523 in patients with relapsed or refractory Hematologic Malignancies